Literature DB >> 2327220

Growth hormone increases rate of pubertal maturation.

F Darendeliler1, P C Hindmarsh, M A Preece, L Cox, C G Brook.   

Abstract

We have performed a retrospective analysis of the pubertal parameters of 134 children with isolated GH insufficiency on GH treatment and compared them to the standards of Tanner and to a recent longitudinal study of growth and development in the United Kingdom. The age at onset of puberty (13.0 years in boys, 12.1 years in girls) was found to be significantly delayed (Mann-Whitney p less than 0.001), but duration of puberty (1.5 years in both sexes) was shortened (Kolgomarov-Smirnov p less than 0.01). Skeletal maturity at the onset of puberty was not advanced excluding this as a contributory factor. There was no association between dose of GH administered and the pubertal parameters. The results suggest that GH accelerates the pubertal process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327220     DOI: 10.1530/acta.0.1220414

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  18 in total

Review 1.  Growth factors and testis.

Authors:  G Giordano; P Del Monte; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

2.  Who's for growth hormone?

Authors:  C G Brook
Journal:  BMJ       Date:  1992-01-18

Review 3.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 4.  Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.

Authors:  B Tönshoff; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

6.  Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty.

Authors:  S Zucchini; E Scarano; L Baldazzi; L Mazzanti; P Pirazzoli; E Cacciari
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

7.  Combined treatment with growth hormone and luteinizing hormone releasing hormone-analogue (LHRHa) of pubertal children with familial short stature.

Authors:  C Volta; S Bernasconi; P Tondi; V Salvioli; L Ghizzoni; A Baldini; A Alberini; C Carani
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

8.  Growth and metabolic consequences of growth hormone treatment in prepubertal short normal children.

Authors:  E S McCaughey; J Mulligan; L D Voss; P R Betts
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

9.  Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation?

Authors:  R Stanhope; M A Preece; G Hamill
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

10.  Growth and puberty after growth hormone treatment after irradiation for brain tumours.

Authors:  A L Ogilvy-Stuart; S M Shalet
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.